rct
    2025
    High Quality

    Selenium vs Control for Graves Ophthalmopathy in a Selenium-Sufficient Area: A Randomized Clinical Trial

    Kim HJ, Jung EH, Chung CW, Park KH, Woo SJ

    Published in JAMA Ophthalmology

    Key Findings

    In a selenium-replete population, selenium supplementation produced no significant improvement in Graves ophthalmopathy activity or quality of life at 6 months.

    Conclusions

    Benefit of selenium appears limited to selenium-deficient populations; no effect in selenium-sufficient regions.

    Supplements Studied

    Selenium
    Mineral

    Selenium supplementation did not improve QOL or clinical parameters in patients with mild to moderate GO in selenium-sufficient regions at 6 months.

    Related Health Concerns

    Graves' Disease
    Hyperthyroidism

    Study Details

    Year:2025
    Sample Size:84
    Quality Score:8/10

    Access Study

    View on DOIOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.